Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

For Consumers

Notification of Counterfeit Serostim

5/20/2002

Serono, Inc. became aware of a counterfeit lot of Serostim [somatropin (rDNA
origin) for injection]. The counterfeit material has been packaged to appear
as drug product lot number S810-1A1. This is not a legitimate Serostim lot
number. Preliminary information appears to indicate that the counterfeit
material may have been distributed via the Internet. However, pharmacists
should examine Serostim prior to dispensing to ensure that the package does
not bear lot number S810-1A1.

Patients should also check the product in their possession to ensure it does not
bear the lot number S810-1A1.

You may access the MedWatch 2002 safety information summary, including links to the
current press release, Dear Doctor Letter, and past MedWatch alerts regarding Serostim, at:

http://www.fda.gov/medwatch/SAFETY/2002/safety02.htm#serost

Richard Klein
Office of Special Health Issues
Food and Drug Administration

Page Last Updated: 08/01/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.